Clinical Trial Update: A Study With CIT-013 in HS Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports that a Phase 2 study of CIT-013 in hidradenitis suppurativa is currently recruiting. The sponsor is Citryll BV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• CIT-013

Snippet

Sponsor: Citryll BV | Conditions: Hidradenitis Suppurativa (HS) | Phase 2 | Status: RECRUITING